In a recent study published in the IJIR: Your Sexual Medicine Journal , a group of researchers used a large United States (U.S.) claims database to assess the risk of developing erectile dysfunction (ED) following a diagnosis of long coronavirus disease (COVID) compared to acute COVID, considering hospitalization status and vasopressor administration.
Study: Comparing risk of post infection erectile dysfunction following SARS Coronavirus 2 stratified by acute and long COVID, hospitalization status, and vasopressor administration: a U.S. large claims database analysis .
Image Credit: Prostock-studio/Shutterstock.com Since the outbreak of COVID-19, over 750 million cases have been confirmed, and nearly 7 million deaths have occurred. Post-COVID-19 sequelae impact many organ systems, including cardiovascular, pulmonary, immunologic, endocrine, vascular, reproductive, and neurologic systems.
These effects raise concerns among professionals who now confront acute and chronic infections. From a urologic perspective, patients face a higher risk of ED following COVID-19. Up to 50.
3% of men developed ED within three months post-infection. Further research is needed to better understand the differential impact of long and acute COVID on ED and to guide more effective prevention and treatment strategies. The present study conducted a retrospective cohort analysis using electronic health records (EHRs) and insurance claims from the TriNetX COVID-19 Research Network, covering over 109 mil.
